FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
01 Jun, 2026, 07.44 AM IST
U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plantThe U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...
29 May, 2026, 12.30 PM IST
Indian pharma firms flood west Africa with powerful opioids despite crackdown: AFP investigationIndian pharmaceutical firms are exporting millions of dollars worth of powerful tapentadol opioids to West Africa, fueling a deadly drugs e...
14 May, 2026, 08.21 AM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
06 May, 2026, 11.19 PM IST
Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
01 May, 2026, 11.26 AM IST
India's 'Mounjaro brides': Weight-loss injections become part of pre-wedding preparationWith wedding season in full swing, Indian health clinics are rolling out specialized weight-loss packages that include popular drugs such a...
03 Apr, 2026, 02.24 PM IST
Drugmakers flag concerns over blue-strip antibiotic labelsThe government mandated a blue line on antibiotic packaging to curb misuse. However, pharmaceutical companies argue this will disrupt opera...
21 Feb, 2026, 12.54 AM IST
DCGI orders withdrawal of cancer drug Olaparib for certain treatmentsThe Drug Controller General of India has requested the withdrawal of AstraZeneca's Olaparib tablets for certain cancer treatments due to po...
23 May, 2024, 12.29 AM IST
Govt bans anti-cold fixed drug combination for under-four childrenThe matter was deliberated in the Subject Expert Committee (SEC- Pulmonary) meeting held on June 6. "The committee recommended that the FDC...
20 Dec, 2023, 08.52 PM IST
Regulator directs drug manufacturers to incorporate new recorded adverse effects in leafletsThe aim is to make the patients and doctors aware of the new adverse reactions of certain drugs which are prescribed frequently for certain...
18 Apr, 2019, 05.38 PM IST
Delhi HC asks government if it approved Biocon’s trastuzumab for three cancersBiosimilars are copies of complex drugs based on living cells. They are different from chemical-based generic drugs, which are 'identical' ...
23 Feb, 2017, 06.05 AM IST
TB, diabetes drug prices to fall by 30%The drug price regulator has capped prices of 30 medicines including antibiotics and those used in treatment of diabetes, tuberculosis and ...
10 May, 2015, 09.30 AM IST
Biocon, Mylan challenge ban on using Roche dataBangalore-based Biocon and US generic drugmaker Mylan have challenged Delhi High Court’s interim order which barred them from using Roche’s...
17 Feb, 2014, 05.16 AM IST
- Pharma cos seek rise in prices of regulated drugs
The domestic pharma industry is going to seek an upward revision in drug prices by submitting a report on the increase in conversion and pa...
11 May, 2009, 01.38 AM IST
- NPPA likely to raise cap on packaging cost of medicines
The proposed move will give a boost to drug manufacturers as packaging costs account for significantly in the determination of regulated dr...
31 Jan, 2009, 12.45 AM IST
- NPPA may allow pharma cos to raise margins
Taking cognisance of the increase in input cost, the National Pharmaceutical Pricing Authority (NPPA) may allow drug makers to raise their ...
30 Jan, 2009, 07.20 PM IST
- Drug cos face stricter checks on road to pricing freedom
Pharmaceutical companies will now have to face in-depth scientific scrutiny on how therapeutically useful are the ingredients that go into ...
06 Jan, 2008, 11.53 PM IST